logo
Big Ten, SEC leaders resume search for compromise with future of CFP, college sports in focus

Big Ten, SEC leaders resume search for compromise with future of CFP, college sports in focus

New York Times17-02-2025

By Ralph D. Russo, Scott Dochterman and Seth Emerson
NEW ORLEANS — Every year around this time, SEC athletic directors meet to go over conference business. This year they have company: Big Ten athletic directors, who moved their annual winter meetings south to join them, along with the commissioners and staff of both conferences.
Advertisement
It is the second such in-person gathering of the leaders of the two wealthiest and most powerful conferences in college sports. They met last October in Nashville and will renew talks Wednesday in an effort to find common ground on some key issues: The future format of the College Football Playoff. Football scheduling. How college sports will be governed and regulated after a settlement in the House v. NCAA lawsuit is approved, allowing schools to pay athletes directly as part of a revenue sharing plan.
The expectation going in is that no major agreements will be finalized this week — unless, with all league leaders in the same room, they realize their interests are aligned enough to do so. The Athletic spoke to a dozen people briefed on the upcoming proceedings about what topics will be discussed. The people spoke on condition of anonymity because they were not authorized to speak publicly about the agenda. Here's a look at the topics of discussion.
While no major changes are likely to be made for the upcoming season to the 12-team format — a tweak to the seeding is possible — just about everything is open to potential change from 2026 onward.
That might seem drastic after just one year of major college football's first true championship tournament, but that's not how administrators see it.
'This format was not built for the current conference alignment,' one AD told The Athletic.
The original expanded CFP structure included spots for the six highest-ranked conference champions, four of which received first-round byes, and six at-large squads. But that was decided before the Pac-12 crumbled as 10 member schools left for the Big Ten, Big 12 and ACC. A last-minute agreement among the CFP's board of managers allowed for five conference champs to pick up automatic bids, with the top four securing byes. But this year, that led to teams ranked ninth (Boise State) and 12th (Arizona State) overall taking the No. 3 and No. 4 seeds, respectively. Ultimately, all four teams with byes lost their quarterfinal games.
Advertisement
The quirky seeding could be addressed for next season's CFP, but it can't be done without eight other conferences and Notre Dame on board — which means it's no lock to change. Last season, No. 1 Oregon faced sixth-ranked Ohio State (bumped back to the No. 8 seed by Boise State's and Arizona State's byes) in a quarterfinal. It seemed like a penalty for the unbeaten Ducks to play the Buckeyes in that round, and Ohio State won that matchup on its way to the national title. It's likely both the Big Ten and SEC will push for seeding changes, but there is urgency required to form a consensus on a range of larger issues. The postseason's new television contract kicks in after this season.
Unlike the current CFP arrangement, any changes to the Playoff structure beginning in 2026 do not require unanimous approval from the FBS conferences and Notre Dame. According to a memo of understanding completed last March when the Playoff's new contract with ESPN was finalized, the Big Ten and SEC have the most impactful voices. Collectively, they can push through format changes without consensus from the CFP board of managers.
'We do have a defined role where we have to be clear participants at the end of that conversation,' SEC commissioner Greg Sankey said after the last SEC-Big Ten summit.
What could change? Just about everything.
Expect a larger field. How big?
'If you're going to go to 14,' another athletic director said, referencing the tweak reportedly floated by Big Ten commissioner Tony Petitti during the discussions last spring, 'why not just go to 16?
Along with adding more participants, establishing a guaranteed number of Playoff spots per conference will once again be up for discussion. According to school officials, the Big Ten is more locked in on guaranteed spots (perhaps as many as four) than the SEC, but there is plenty of interest within the SEC. Coincidentally, the Big Ten earned more CFP spots (four) in the first year of the 12-team format than the SEC (three), which would have benefited from more dedicated qualifiers per conference.
Advertisement
Any move toward guaranteed spots for the leagues' top teams, however, also would need to come with a reimagination of how conference championship games work. One possibility is using championship weekend as a CFP play-in weekend. In addition to the Big Ten and SEC championships, there would be play-in games between the third and sixth seeds and fourth and fifth seeds and perhaps throughout the leagues' entire lineup.
The sorting of matchups by record is a similar concept to what the Big Ten tried to institute at the end of the COVID-19-altered 2020 season. The idea was floated late last year, each school has had a chance to think about it, and the New Orleans meeting will offer a chance for everyone to exchange notes and thoughts.
Other iterations of this concept are likely to come up. How about four play-in games matching the top eight teams in the conference, essentially turning championship weekend into the first weekend of the CFP, with a bunch of win-or-go-home games instead of title games between teams only playing for seeding?
The conferences don't necessarily need to agree on how their auto-bids are determined, but there is a growing recognition that uniformity between Big Ten and SEC is necessary to create equitable paths to a national championship.
The football programs that make up the SEC and Big Ten have outpaced their conference rivals on the field and in the bank. But the greatest disparity lies in the television ratings.
Of the highest-rated 20 games in each of the last two seasons, 65 of the 80 teams involved belong currently to either the Big Ten (34) or SEC (31). All but two of those 40 games (Colorado-Colorado State in 2023, Army-Navy in 2024) involved at least one of the leagues.
With the sport's greatest brands and visibility, it makes sense for the leagues to explore a ratings-friendly annual football series, like the former SEC-Big 12 challenge and Big Ten-ACC challenge in basketball. Schools and league officials discussed the possibility last fall, but there are hurdles.
Advertisement
One potential deal-breaker: SEC schools play eight league contests and one other power-conference opponent, while the Big Ten has played nine conference games since 2016. In addition, 13 of the Big Ten's 18 schools play at least 10 power-conference games this fall. In the SEC, 13 of the 16 schools face only nine power-conference teams.
'We obviously can't force them to play nine (conference) games. They have to do what's best for them,' Ohio State athletic director Ross Bjork told The Athletic during football season. 'But now that I'm in the Big Ten, I like it. I think it does draw value. I think it provides your fans with marquee matchups. That's what fans want. There's a noticeable difference in terms of just overall revenue around a Big Ten game versus a nonconference game against the Group of 5.'
Bjork was a strong proponent of a nine-game SEC schedule during his previous stints as AD at Ole Miss and Texas A&M. He added, 'I do believe there is a desire to get to nine games within the SEC.'
Another hurdle: Both leagues have teams that play treasured rivalry games against teams in other conferences. Florida, Georgia, Kentucky and South Carolina all play in-state ACC foes, while Iowa, Oregon and Washington also have in-state rivalries. So a Big Ten-SEC crossover series would lock in an 11th power-conference game for each of the Big Ten schools, and never mind any other scheduled future series.
Each conference's media partners would benefit from that arrangement, and perhaps a group of SEC-Big Ten games could be packaged and sold to advertisers. Still, one athletic director indicated those discussions are on the backburner now.
'We can't make decisions on regular-season scheduling until we know what the Playoff will be,' that AD said.
The SEC's future schedule, meanwhile, will be discussed when its athletic directors meet on Tuesday. It's unlikely a decision will be announced then, unless ESPN shows up with financial assurances that would push enough schools into the nine-game camp. Barring that, it's likely a decision will be made later this spring to do another temporary eight-game rotation that covers the 2026 and '27 seasons.
Advertisement
But there is still hope among nine-game advocates that television money will come through and move the reluctant to agree to expand. The goal is to have some sort of decision by SEC spring meetings in late May.
There are limits to how much two conferences can collaborate when it comes to how they will approach revenue sharing because collaboration can slip into collusion and open them up to more antitrust lawsuits.
'Our legal counsel is very skilled at this point in defining the boundaries, what we can talk about and we cannot talk about,' Sankey said after the first summit.
Still, there is work being done among the Power 4 leagues — including the Big 12 and the ACC — which agreed as part of the settlement to set up an outside entity that will handle enforcement of its new rules: a cap on revenue sharing, roster limits and a system to evaluate the fair market value of name, image and likeness compensation deals between athletes and third parties. The NCAA will still oversee and enforce rules related to academic eligibility.
The settlement terms still must be approved by Judge Claudia Wilken, who scheduled a final hearing on April 7. Wilken granted preliminary approval on Oct. 7, 2024.
SEC and Big Ten athletic directors are likely to hear an update from their colleagues who are working on setting up a limited liability corporation (LLC) to provide enforcement and oversight.
Exactly what that entity will enforce needs clarification. The settlement terms set up parameters, but details still need to be hashed out. For example, a roster limit for football has been set at 105 for competition and practice during the season. What about during the offseason? Can teams have more players training with the team throughout the spring and summer? If those players are not on scholarship or receiving rev-share payments, can they receive other benefits through the school?
Advertisement
NCAA governance is also in the process of being reformed. Six proposals have been presented to the association, including one from the Power 4 and another from the 22 Division I conferences that don't sponsor football at the highest level.
The P4's proposal includes those conferences taking over the operation of championship events, a prospect that has been met with some skepticism by the rest of Division I, which is most protective of access to those events and the revenue they produce.
An NCAA subcommittee composed of representatives from the groups that presented proposals is scheduled later this month to begin digging into the various pitches with the hope of reaching a compromise.
Once the new rules are set by the House settlement and new NCAA governance is in place, many officials say, everyone needs to agree to work together, even if it's to their own school's detriment.
With college athletics changing so rapidly, and the NCAA taking a reduced role in oversight and enforcement, it makes sense for the industry's most powerful leagues to fill that leadership vacuum and provide a new way forward. What league officials discuss and decide at this week's summit will have a direct bearing on what the future holds in all facets of college athletics.
(Photo of Tony Petitti and Greg Sankey: Kirby Lee / USA Today)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

LSU baseball vs. UCLA in College World Series: Key storylines as Tigers look to go 2-0
LSU baseball vs. UCLA in College World Series: Key storylines as Tigers look to go 2-0

USA Today

time32 minutes ago

  • USA Today

LSU baseball vs. UCLA in College World Series: Key storylines as Tigers look to go 2-0

LSU baseball vs. UCLA in College World Series: Key storylines as Tigers look to go 2-0 After opening the College World Series with a win over Arkansas, LSU baseball is set to face UCLA on Monday night. LSU is two wins away from punching a ticket to the CWS final. 74% of CWS final teams begin bracket play 2-0. If LSU can take that step on Monday, the Tigers are right on track for a national title. LSU head coach Jay Johnson and the Tigers are looking for their second national title in three years. LSU won the CWS in 2023 behind star performances from Paul Skenes and Dylan Crews. LSU's current roster isn't quite as talented as the 23 roster, but it's still filled with future pros. The Tigers are led by an elite starting pitching duo of Kade Anderson and Anthony Eyanson. At the plate, superstar freshman Derek Curiel continues to be one of the sport's most consistent hitters. Here's everything you need to know before LSU baseball meets UCLA on Monday night. Anthony Eyanson looks to follow up Kade Anderson LSU ace went seven innings vs. Arkansas, allowing just one run and three hits. Anderson struck out seven and walked two. Eyanson looks to pull off a similar feat on Monday. All year, Anderson and Eyanson have been ace 1A and 1B. Anderson leads the country with 170 strikeouts. Eyanson ranks No. 3 with 142. Eyanson has a 2.74 ERA in 98.2 innings and keeps the ball in the park, only allowing six home runs in 2025. Eyanson has a four-pitch mix. That's something you don't often see at the college level. The fastball sits mid-90s, paired with a power slider and a strong curveball. He'll throw a change-up, too, but he relies on the fastball-slider-curveball mix. Eyanson's first month as a Tiger was up and down, but he found a different gear in late March. Eyanson has not surrendered an earned run in six of his last 12 appearances. Going back to March 28, Eyanson's ERA is 1.89. He was a tad shaky in the super regional, allowing four runs over five innings, but most of that came from home runs. This is the biggest moment of Eyanson's career, but he's delivered in the clutch when called upon. Expect Eyanson to have his best stuff on Monday. UCLA will start Landon Stump Taking the ball for UCLA is sophomore Landon Stump. Stump has a 4.54 ERA in 73.1 innings. His strikeout to walk ratio is just 1.1, which ranked 43rd among College World Series pitchers with 30+ innings pitched. The stuff is there, but the consistency isn't. Stump has only pitched 8.1 innings in his last three outings and due to UCLA's light schedule in the Big Ten, he's not used to facing a lineup like LSU's. The best offense Stump saw in 2025 was Oregon, where the Ducks tagged on six earned runs in 3.2 innings. Stump had just one strikeout. That doesn't paint a pretty picture, but don't write him off. Stump pitched four innings in the super regional vs. UTSA and didn't allow a run. The Bruins don't need a dazzling, eight-inning performance from the righty. They just need Stump to keep the game under control for a few innings. If Stump is throwing strikes, that's possible. If the command struggles early, he could unravel vs. this LSU lineup that has been opportunistic of late. Is there concern about LSU's lineup? Speaking of that LSU lineup, there are a few questions. The Tigers got the job done vs. Arkansas, but the first three hitters in the order went a combined 0-13. That included a 0-5 night from Jared Jones. LSU's three-run second inning knocked Arkansas ace Zach Root out of the game, but only one ball left the infield. On the night, LSU had one extra base hit. Thanks to Kade Anderson and the LSU pitching staff, four runs were enough. But there's going to be a time when LSU needs more. LSU won't face the same quality of arm vs. UCLA that it saw with Arkansas. If LSU continues to struggle to find power on Monday, it's a bad sign. Derek Curiel and Steven Milam have been clutch throughout the postseason, but LSU is at its best when guys like Ethan Frey and Jared Jones are getting in on the party. LSU matches up well with the UCLA starter. The Tigers hit righties and know how to take walks. When UCLA hands LSU free passes, the Tigers need to find the big swing and cash in. What shape is the LSU bullpen in? After Anderson's seven innings, LSU turned to Chase Shores and Casan Evans out of the pen. Shores threw 10 pitches and Evans threw 13. That should leave them both available on Monday. Evans and Shores would both be considered to start LSU's next game, win or lose. With that in mind, we could see Jay Johnson turn to Cooper Williams or Zac Cowan on Monday. Williams, a true freshman, delivered for LSU in the regional and super regional. Cowan, a Wofford transfer, was the SEC's top closer for much of the year but struggled as of late. If LSU is going to get where it wants to go, it probably involves Cowan figuring some things out.

FibroBiologics to Present at the BIO International Convention 2025
FibroBiologics to Present at the BIO International Convention 2025

Yahoo

timean hour ago

  • Yahoo

FibroBiologics to Present at the BIO International Convention 2025

HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ('FibroBiologics'), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O'Heeron, will present a company update at the BIO International Convention 2025, June 16-19, 2025, in Boston, MA. The presentation will include recent corporate milestones and research advances using fibroblast-based technology for indications such as wound healing, multiple sclerosis, and psoriasis. 'The BIO International Convention provides an ideal platform to showcase how FibroBiologics is potentially transforming the treatment landscape for chronic diseases,' said Pete O'Heeron. 'With our Phase 1/2 clinical trial in diabetic foot ulcers wound healing set to begin later this year, we are demonstrating that fibroblast-based therapies have the potential to address the underlying biological dysfunction rather than managing symptoms. This could represent a fundamental shift in how we approach the treatment of chronic diseases.' Details of the presentation are as follows: Date: Tuesday, June 17, 2025Time: 10:45 a.m. ETLocation: Boston Convention & Exhibition Center, Room 154 To learn more about the event, please visit or to schedule one-on-one meetings, please email FibroBiologicsIR@ Cautionary Statement Regarding Forward-Looking Statements This communication contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning plans for, and the timing of, clinical trials. These forward-looking statements are based on FibroBiologics' management's current expectations, estimates, projections and beliefs, as well as a number of assumptions concerning future events. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside FibroBiologics' management's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including those set forth under the caption "Risk Factors" and elsewhere in FibroBiologics' annual, quarterly and current reports (i.e., Form 10-K, Form 10-Q and Form 8-K) as filed or furnished with the SEC and any subsequent public filings. Copies are available on the SEC's website, These risks, uncertainties, assumptions and other important factors include, but are not limited to: (a) risks related to FibroBiologics' liquidity and its ability to maintain capital resources sufficient to conduct its business; (b) expectations regarding the initiation, progress and expected results of our R&D efforts and preclinical studies; (c) the unpredictable relationship between R&D and preclinical results and clinical study results; and (d) the ability of FibroBiologics to successfully prosecute its patent applications. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FibroBiologics assumes no obligation and, except as required by law, does not intend to update, or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. FibroBiologics gives no assurance that it will achieve its expectations. About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit General Inquiries:info@ Investor Relations:Nic JohnsonRusso Partners(212) 845-4242fibrobiologicsIR@ Media Contact:Liz PhillipsRusso Partners(347)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store